Correction to : Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta‑Analysis
The authors unintentionally included in the meta-analysis both the initial abstract and the final paper of the study by Puertolas et al. [45, 48]. In order to remove this duplication, the following corrections are required.
| Errataetall: |
ErratumFor: BioDrugs. 2019 Aug;33(4):373-389. - PMID 31161461 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy - 33(2019), 5 vom: 21. Okt., Seite 589-594 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yang, Jichun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 08.01.2020 published: Print ErratumFor: BioDrugs. 2019 Aug;33(4):373-389. - PMID 31161461 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s40259-019-00378-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301508321 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301508321 | ||
| 003 | DE-627 | ||
| 005 | 20231225104757.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40259-019-00378-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1005.xml |
| 035 | |a (DE-627)NLM301508321 | ||
| 035 | |a (NLM)31542853 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yang, Jichun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta‑Analysis |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 08.01.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: BioDrugs. 2019 Aug;33(4):373-389. - PMID 31161461 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The authors unintentionally included in the meta-analysis both the initial abstract and the final paper of the study by Puertolas et al. [45, 48]. In order to remove this duplication, the following corrections are required | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Yu, Shuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Zhirong |e verfasserin |4 aut | |
| 700 | 1 | |a Yan, Yusong |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yao |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Hongmei |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Yanxia |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Yehui |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zilu |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Feng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy |d 1997 |g 33(2019), 5 vom: 21. Okt., Seite 589-594 |w (DE-627)NLM096446870 |x 1179-190X |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2019 |g number:5 |g day:21 |g month:10 |g pages:589-594 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40259-019-00378-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2019 |e 5 |b 21 |c 10 |h 589-594 | ||